Patents by Inventor Hans F. Huebner

Hans F. Huebner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4600718
    Abstract: There is disclosed a method of treating weight loss disorders. This method consists essentially of administering to a mammal, such as a human, a daily dosage of at least about 10 milligrams per 37 kilogram body weight of at least one opiate antagonist. These opiate antagonists include naloxone, naltrexone, nalorphine, diprenorphine, levallorphan, pentazocine, metazocine, cyclozocine, etazocine, and pharmacologically acceptable salts thereof. The use of naloxone hydrochloride as the opiate antagonist is preferred.
    Type: Grant
    Filed: June 6, 1985
    Date of Patent: July 15, 1986
    Inventor: Hans F. Huebner
  • Patent number: 4546103
    Abstract: There is disclosed a method of treating weight loss disorders. This method consists essentially of administering to a mammal, such as a human, a daily dosage of at least about 10 milligrams per 37 kilogram body weight of at least one opiate antagonist. These opiate antagonists include naloxone, naltrexone, nalorphine, diprenorphine, levallorphan, pentazocine, metazocine, cyclozocine, etazocine, and pharmacologically acceptable salts thereof. The use of naloxone hydrochloride as the opiate antagonist is preferred.
    Type: Grant
    Filed: September 18, 1984
    Date of Patent: October 8, 1985
    Inventor: Hans F. Huebner